488 related articles for article (PubMed ID: 16382466)
1. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching.
Kamei H; Oike F; Fujimoto Y; Yamamoto H; Tanaka K; Kiuchi T
Liver Transpl; 2006 Jan; 12(1):140-5. PubMed ID: 16382466
[TBL] [Abstract][Full Text] [Related]
2. Graft-versus-host disease following living donor liver transplantation.
Soejima Y; Shimada M; Suehiro T; Hiroshige S; Gondo H; Takami A; Yasue S; Maehara Y
Liver Transpl; 2004 Mar; 10(3):460-4. PubMed ID: 15004778
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
[TBL] [Abstract][Full Text] [Related]
4. Relevance of HLA compatibility in living donor liver transplantation: the double-edged sword associated with the patient outcome.
Uchiyama H; Kayashima H; Matono R; Shirabe K; Yoshizumi T; Ikegami T; Soejima Y; Matsuura T; Taguchi T; Maehara Y
Clin Transplant; 2012; 26(5):E522-9. PubMed ID: 23061761
[TBL] [Abstract][Full Text] [Related]
5. Acute graft-versus-host disease after living donor liver transplantation with donor-dominant one-way human leukocyte antigen matching at two Loci.
Shimizu T; Hayashi M; Inoue Y; Komeda K; Asakuma M; Hirokawa F; Iwamoto M; Miyamoto Y; Yonetani N; Saji H; Haga H; Tanigawa N
Transplantation; 2010 May; 89(9):1164-6. PubMed ID: 20440198
[No Abstract] [Full Text] [Related]
6. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
[TBL] [Abstract][Full Text] [Related]
7. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.
Sasazuki T; Juji T; Morishima Y; Kinukawa N; Kashiwabara H; Inoko H; Yoshida T; Kimura A; Akaza T; Kamikawaji N; Kodera Y; Takaku F
N Engl J Med; 1998 Oct; 339(17):1177-85. PubMed ID: 9780337
[TBL] [Abstract][Full Text] [Related]
8. Acute graft versus host disease following living donor liver transplantation: first Korean report.
Cho EH; Suh KS; Yang SH; Lee HW; Cho JY; Cho YB; Yi NJ; Lee KU
Hepatogastroenterology; 2007; 54(79):2120-2. PubMed ID: 18251173
[TBL] [Abstract][Full Text] [Related]
9. Unusual onset of chronic graft-versus-host disease after adult living-related liver transplantation from a homozygous donor.
Nemoto T; Kubota K; Kita J; Shimoda M; Rokkaku K; Tagaya N; Fujiwara T; Sunakawa M
Transplantation; 2003 Mar; 75(5):733-6. PubMed ID: 12640319
[TBL] [Abstract][Full Text] [Related]
10. Fatal Graft-Versus-Host Disease Following Adult-To-Adult Living Donor Liver Transplantation From an HLA Nonhomozygous Donor.
Yu YD; Kim DS; Ha N; Jung SW; Han JH; Kim JY; Park SH; Cho YJ
Prog Transplant; 2016 Dec; 26(4):394-396. PubMed ID: 27555077
[TBL] [Abstract][Full Text] [Related]
11. Influence of human leukocyte antigen matching on long-term outcome after lung transplantation.
Wisser W; Wekerle T; Zlabinger G; Senbaclavaci O; Zuckermann A; Klepetko W; Wolner E
J Heart Lung Transplant; 1996 Dec; 15(12):1209-16. PubMed ID: 8981206
[TBL] [Abstract][Full Text] [Related]
12. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis.
Morioka D; Egawa H; Kasahara M; Jo T; Sakamoto S; Ogura Y; Haga H; Takada Y; Shimada H; Tanaka K
Liver Transpl; 2007 Jan; 13(1):80-90. PubMed ID: 16964594
[TBL] [Abstract][Full Text] [Related]
13. Living donor liver transplantation in high-risk vs. low-risk patients: optimization using statistical models.
Durand F; Belghiti J; Troisi R; Boillot O; Gadano A; Francoz C; de Hemptinne B; Mallet A; Valla D; Golmard JL
Liver Transpl; 2006 Feb; 12(2):231-9. PubMed ID: 16447208
[TBL] [Abstract][Full Text] [Related]
14. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
[TBL] [Abstract][Full Text] [Related]
15. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation.
Loiseau P; Espérou H; Busson M; Sghiri R; Tamouza R; Hilarius M; Raffoux C; Devergie A; Ribaud P; Socié G; Gluckman E; Charron D
Bone Marrow Transplant; 2002 Oct; 30(8):497-502. PubMed ID: 12379888
[TBL] [Abstract][Full Text] [Related]
16. [HLA typing in the Japanese Bone Marrow Program].
Akaza T
Rinsho Byori; 1997 Feb; 45(2):157-60. PubMed ID: 9121000
[TBL] [Abstract][Full Text] [Related]
17. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
Morishima Y; Yabe T; Matsuo K; Kashiwase K; Inoko H; Saji H; Yamamoto K; Maruya E; Akatsuka Y; Onizuka M; Sakamaki H; Sao H; Ogawa S; Kato S; Juji T; Sasazuki T; Kodera Y;
Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
[TBL] [Abstract][Full Text] [Related]
18. Influence of HLA compatibility and lymphocyte cross-matching on acute cellular rejection following living donor adult liver transplantation.
Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
Liver Int; 2005 Dec; 25(6):1182-8. PubMed ID: 16343070
[TBL] [Abstract][Full Text] [Related]
19. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract][Full Text] [Related]
20. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.
Taylor AL; Gibbs P; Sudhindran S; Key T; Goodman RS; Morgan CH; Watson CJ; Delriviere L; Alexander GJ; Jamieson NV; Bradley JA; Taylor CJ
Transplantation; 2004 Feb; 77(3):441-6. PubMed ID: 14966423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
